HSG Holding’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Hold |
1,420,473
| – | – | 0.07% | 17 |
|
|
2025
Q1 | $1.16M | Hold |
1,420,473
| – | – | 0.07% | 15 |
|
|
2024
Q4 | $1.39M | Hold |
1,420,473
| – | – | 0.06% | 16 |
|
|
2024
Q3 | $1.89M | Hold |
1,420,473
| – | – | 0.07% | 16 |
|
|
2024
Q2 | $1.95M | Hold |
1,420,473
| – | – | 0.07% | 15 |
|
|
2024
Q1 | $3.62M | Hold |
1,420,473
| – | – | 0.34% | 13 |
|
|
2023
Q4 | $4.3M | Hold |
1,420,473
| – | – | 0.5% | 14 |
|
|
2023
Q3 | $4.39M | Hold |
1,420,473
| – | – | 0.47% | 16 |
|
|
2023
Q2 | $2.93M | Hold |
1,420,473
| – | – | 0.33% | 15 |
|
|
2023
Q1 | $3.18M | Hold |
1,420,473
| – | – | 0.33% | 14 |
|
|
2022
Q4 | $3.34M | Hold |
1,420,473
| – | – | 0.34% | 14 |
|
|
2022
Q3 | $4.55M | Hold |
1,420,473
| – | – | 0.49% | 15 |
|
|
2022
Q2 | $6.32M | Buy |
+1,420,473
| New | +$6.32M | 0.58% | 13 |
|